AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.605
-0.305 (-10.47%)
At close: Feb 18, 2026, 4:00 PM EST
2.620
+0.015 (0.57%)
After-hours: Feb 18, 2026, 4:10 PM EST

AC Immune Revenue

AC Immune had revenue of 939.00K CHF in the quarter ending September 30, 2025, a decrease of -96.32%. This brings the company's revenue in the last twelve months to 4.37M, down -89.33% year-over-year. In the year 2024, AC Immune had annual revenue of 27.31M with 84.51% growth.

Revenue (ttm)
4.37M CHF
Revenue Growth
-89.33%
P/S Ratio
47.28
Revenue / Employee
25,419 CHF
Employees
172
Market Cap
257.77M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202427.31M12.51M84.51%
Dec 31, 202314.80M10.87M276.14%
Dec 31, 20223.94M--
Dec 31, 2021---
Dec 31, 202015.43M-95.03M-86.03%
Dec 31, 2019110.46M103.54M1,498.03%
Dec 31, 20186.91M-13.34M-65.88%
Dec 31, 201720.26M-2.96M-12.75%
Dec 31, 201623.21M-15.88M-40.61%
Dec 31, 201539.09M8.82M29.14%
Dec 31, 201430.27M21.63M250.46%
Dec 31, 20138.64M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Coherus Oncology277.73M
X4 Pharmaceuticals33.98M
OmniAb21.09M
Opus Genetics14.63M
Shattuck Labs1.00M
Neurogene925.00K
Inhibikase Therapeutics1.00
Revenue Rankings